Quantification of hydroxyl radical and its lack of relevance to myocardial injury during early reperfusion after graded ischemia in rat hearts.

To elucidate the pathophysiological role of the hydroxyl radical (.OH) during the postischemic reperfusion of the heart, we measured the .OH product in the coronary effluent from isolated perfused rat heart during a 30-minute reperfusion period after various ischemic intervals of 5, 10, 15, 20, 30, and 60 minutes. Salicylic acid was used as the probe for .OH, and its derivative, 2,5-dihydroxybenzoic acid (2,5-DHBA), was quantified using high-performance liquid chromatography with ultraviolet detection. 2,5-DHBA was negligible in the effluent from nonischemic hearts, but a significant amount was detected from the hearts rendered ischemic for 10 minutes or longer. The peak of 2,5-DHBA was seen within 90 seconds after the onset of reperfusion in every group. The accumulated amount of 2,5-DHBA was maximal in the group with 15-minute ischemia (6.73 +/- 1.04 nmol/g wet heart wt after 30 minutes of reperfusion); it decreased as the ischemic time was prolonged and was 2.38 +/- 0.84 nmol/g wet wt after 30 minutes of reperfusion in the group with 60-minute ischemia. In the model of 15-minute ischemia/30-minute reperfusion, there was no correlation between the accumulated amount of 2,5-DHBA and functional recovery (+/- dP/dt, heart rate, and coronary flow), lactate dehydrogenase release, and morphological damage. Although treatment with 0.5 mM deferoxamine, an iron chelator, significantly decreased 2,5-DHBA (from 6.73 +/- 1.04 to 2.29 +/- 0.80 nmol/g wet wt after 30 minutes of reperfusion, p less than 0.01), it failed to reduce the postischemic myocardial injury in the group with 15-minute ischemia. The results suggest that .OH production is influenced by the preceding ischemic interval and that .OH does not exert an immediate direct effect on postischemic damage during early reperfusion in the isolated perfused rat heart, although a possibility remains that the small portion of .OH trapped by salicylic acid may not be intimately associated with myocardial injury.

[1]  W. Weglicki,et al.  Postischemic Free Radical Production in the Venous Blood of the Regionally Ischemic Swine Heart: Effect of Deferoxamine , 1991, Circulation.

[2]  T. Onodera,et al.  Detection of hydroxyl radicals in the post-ischemic reperfused heart using salicylate as a trapping agent. , 1991, Journal of molecular and cellular cardiology.

[3]  J. Zweier,et al.  Treatment With Deferoxamine During Ischemia Improves Functional and Metabolic Recovery and Reduces Reperfusion‐Induced Oxygen Radical Generation in Rabbit Hearts , 1991, Circulation.

[4]  M. Ingelman-Sundberg,et al.  Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. , 1991, Free radical biology & medicine.

[5]  R. Bolli,et al.  Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning". , 1990, The American journal of physiology.

[6]  R. Bolli Mechanism of Myocardial “Stunning” , 1990, Circulation.

[7]  L. Horwitz,et al.  Deferoxamine pretreatment reduces canine infarct size and oxidative injury. , 1990, The Journal of pharmacology and experimental therapeutics.

[8]  S. Powell,et al.  Use of salicylate as a probe for .OH formation in isolated ischemic rat hearts. , 1990, Free radical biology & medicine.

[9]  V. Richard,et al.  The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy? , 1989, Journal of molecular and cellular cardiology.

[10]  M. Weisfeldt,et al.  Measurement and characterization of postischemic free radical generation in the isolated perfused heart. , 1989, The Journal of biological chemistry.

[11]  R. Kloner,et al.  Deleterious Effects of Oxygen Radicals in Ischemia/Reperfusion Resolved and Unresolved Issues , 1989, Circulation.

[12]  B. Britigan,et al.  Spin-trapping and human neutrophils. Limits of detection of hydroxyl radical. , 1989, The Journal of biological chemistry.

[13]  D. Yellon,et al.  Inability of desferrioxamine to limit tissue injury in the ischaemic and reperfused rabbit heart. , 1989, Journal of cardiovascular pharmacology.

[14]  L. Horwitz,et al.  Dimethylthiourea, but not dimethylsulfoxide, reduces canine myocardial infarct size. , 1989, Free radical biology & medicine.

[15]  R. Kloner,et al.  Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. , 1989, Free radical biology & medicine.

[16]  H. Swartz,et al.  The cellular-induced decay of DMPO spin adducts of .OH and .O2. , 1989, Free radical biology & medicine.

[17]  N. Sperelakis,et al.  Myocardial dysfunction and ultrastructural alterations mediated by oxygen metabolites. , 1988, Journal of molecular and cellular cardiology.

[18]  R. Bolli,et al.  Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. , 1988, The Journal of clinical investigation.

[19]  G. Gross,et al.  Evidence For a Role of Iron‐Catalyzed Oxidants in Functional and Metabolic Stunning in the Canine Heart , 1988, Circulation research.

[20]  J. Zweier Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. , 1988, The Journal of biological chemistry.

[21]  C. Arroyo,et al.  Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO , 1992, FEBS letters.

[22]  P. O’Neill,et al.  The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. , 1987, The American journal of physiology.

[23]  T. Slater,et al.  Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. , 1987, Circulation research.

[24]  M. Weisfeldt,et al.  Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. , 1987, Circulation.

[25]  P. J. Simpson,et al.  Free radicals and myocardial ischemia and reperfusion injury. , 1987, The Journal of laboratory and clinical medicine.

[26]  A. Simmons,et al.  Protection from reperfusion injury in the isolated rat heart by postischaemic deferoxamine and oxypurinol administration. , 1987, Cardiovascular research.

[27]  M. Weisfeldt,et al.  Direct measurement of free radical generation following reperfusion of ischemic myocardium , 1987 .

[28]  R. Engler Granulocytes and oxidative injury in myocardial ischemia and uperfusion , 1987 .

[29]  C. Arroyo,et al.  Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production. , 1987, Free radical biology & medicine.

[30]  B. Lucchesi,et al.  O2 free radical-mediated myocardial and vascular dysfunction. , 1986, The American journal of physiology.

[31]  R. Myklebust,et al.  Influence of oxygen radicals generated by xanthine oxidase in the isolated perfused rat heart. , 1986, Cardiovascular research.

[32]  B. Halliwell,et al.  Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids. , 1986, The Biochemical journal.

[33]  B. Fanburg,et al.  Influence of exogenously generated oxidant species on myocardial function. , 1986, The American journal of physiology.

[34]  M. Bernier,et al.  Reperfusion‐induced Arrhythmias and Oxygen‐derived Free Radicals: Studies with “Anti‐Free Radical” Interventions and a Free Radical‐generating System in the Isolated Perfused Rat Heart , 1986, Circulation research.

[35]  R. Floyd,et al.  Use of salicylate with high pressure liquid chromatography and electrochemical detection (LCED) as a sensitive measure of hydroxyl free radicals in adriamycin treated rats. , 1986, Journal of free radicals in biology & medicine.

[36]  J. McCord,et al.  Oxygen-derived free radicals in postischemic tissue injury. , 1985, The New England journal of medicine.

[37]  T. Florence The production of hydroxyl radical from hydrogen peroxide , 1984 .

[38]  R. Floyd,et al.  Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. , 1984, Journal of biochemical and biophysical methods.

[39]  M. Hess,et al.  Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. , 1984, Journal of molecular and cellular cardiology.

[40]  S. Bolling,et al.  The mechanism of mannitol in reducing ischemic injury: hyperosmolarity or hydroxyl scavenger? , 1984, Circulation.

[41]  G. Ghai,et al.  Myocardial alterations due to free-radical generation. , 1984, The American journal of physiology.

[42]  I. Grupp,et al.  Isolated Heart Preparations Perfused or Superfused with Balanced Salt Solutions , 1984 .

[43]  G. Rosen,et al.  Spin trapping of superoxide and hydroxyl radicals. , 1984, Methods in enzymology.

[44]  M. Hess,et al.  Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum. Participation of the cyclooxygenase pathway. , 1983, Circulation research.

[45]  B. Halliwell,et al.  Reactions of ferrioxamine and desferrioxamine with the hydroxyl radical. , 1982, Chemico-biological interactions.

[46]  J. Gavin,et al.  Catecholamine-depletion and the no-reflow phenomenon in anoxic and ischaemic rat hearts. , 1982, Journal of molecular and cellular cardiology.

[47]  B. Halliwell,et al.  Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. , 1979, The Biochemical journal.

[48]  C. Winterbourn Comparison of superoxide with other reducing agents in the biological production of hydroxyl radicals. , 1979, The Biochemical journal.

[49]  B. Halliwell Superoxide‐dependent formation of hydroxyl radicals in the presence of iron chelates , 1978, FEBS letters.